* Rxsight Inc RXST.OQ reported a quarterly adjusted loss
of 61
cents per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for a loss
of 71 cents per share.
* Revenue rose 118% to $12.62 million from a year ago;
analysts
expected $10.98 million.
* Rxsight Inc's reported EPS for the quarter was a loss
of 61
cents.
* The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Rxsight Inc shares had fallen by 2.5% this quarter and
gained 4.0% so far this year.
* The company reported a quarterly loss of $16.82 million.
* Wall Street's median 12-month price target for Rxsight Inc
is
$22.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 04:02 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.71 -0.61 Beat
Jun. 30 2022 -0.69 -0.61 Beat
Mar. 31 2022 -0.65 -0.64 Beat
Dec. 31 2021 -0.68 -0.58 Beat